Zobrazeno 1 - 10
of 17
pro vyhledávání: '"W. P. Sheridan"'
Autor:
W. P. Sheridan, C. F. Toombs
Publikováno v:
Hämostaseologie. 16:107-113
SummarySince the announcement of the discovery of thrombopoietin in 1994, a tremendous amount of research has determined that recombinant c-mpl ligand (ML) is capable of producing the biological effects of a Meg-CSF and thrombopoietin. Thrombopoietin
Publikováno v:
2000 Power Engineering Society Summer Meeting (Cat. No.00CH37134).
The structure of a market for energy is a fundamental design problem in the move towards competition in the electricity supply industry. Many systems have moved away from the traditional methods of central optimisation towards auction mechanisms. How
Autor:
J A, Glaspy, E J, Shpall, C F, LeMaistre, R A, Briddell, D M, Menchaca, S A, Turner, M, Lill, L, Chap, R, Jones, M D, Wiers, W P, Sheridan, I K, McNiece
Publikováno v:
Blood. 90(8)
The safety and optimal dose and schedule of stem cell factor (SCF) administered in combination with filgrastim for the mobilization of peripheral blood progenitor cells (PBPCs) was determined in 215 patients with high-risk breast cancer. Patients rec
Autor:
T R, Ulich, J, del Castillo, G, Senaldi, O, Kinstler, S, Yin, S, Kaufman, J, Tarpley, E, Choi, T, Kirley, P, Hunt, W P, Sheridan
Publikováno v:
Blood. 87(12)
PEG-rHuMGDF injected daily in normal mice causes a rapid dose-dependent increase in megakaryocytes and platelets. At the same time that platelet numbers are increased, the mean platelet volume (MPV) and platelet distribution width (PDW) can be either
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.
Publikováno v:
Bone marrow transplantation. 11(2)
Four patients with acute myeloid leukaemia relapsed within 6 months of allogeneic BMT. Three patients were treated with cytosine arabinoside and amsacrine while the fourth received no chemotherapy. All patients received infusions of leucocytes obtain
Autor:
A, Grigg, C G, Begley, C A, Juttner, J, Szer, L B, To, D, Maher, K M, McGrath, G, Morstyn, R M, Fox, W P, Sheridan
Publikováno v:
Bone marrow transplantation. 11
The haematopoietic growth factor (HGF), granulocyte colony stimulating factor (G-CSF; filgrastim) substantially shortens the period of severe neutropenia that follows high-dose chemotherapy and autologous bone marrow infusion by stimulating granulopo
Autor:
G, Morstyn, W P, Sheridan
Publikováno v:
Cancer chemotherapy and biological response modifiers. 14
Autor:
J, Szer, W P, Sheridan
Publikováno v:
Transplantation proceedings. 24(1)
Autor:
G, Morstyn, W P, Sheridan
Publikováno v:
Cancer chemotherapy and biological response modifiers. 13